Pfizer Inc. et al v. MSN Pharmaceuticals Inc. et al > Summary
Court Case Number 1:21-cv-00139
Filing Date Feb 3, 2021
Termination Date Aug 24, 2021
Court Delaware District Court
Status Dismissed - Settled
JudgesColm F. Connolly
Plaintiff Attorneys
14Pfizer Legal Division 2
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Pfizer Legal Division 2
Attorney Name: Christopher J. Mandernach
Williams & Connolly
Warner-Lambert Company
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Warner-Lambert Company
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Warner-Lambert Company
Attorney Name: Christopher J. Mandernach
Williams & Connolly
PF PRISM IMB B.V.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
PF PRISM IMB B.V.
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
PF PRISM IMB B.V.
Attorney Name: Christopher J. Mandernach
Williams & Connolly
Pfizer Legal Division 2
Attorney Name: David I. Berl
Williams & Connolly
Pfizer Legal Division 2
Attorney Name: Xun Liu
Williams & Connolly
Warner-Lambert Company
Attorney Name: Andrew L. Hoffman
Williams & Connolly
Pfizer Legal Division 2
Attorney Name: Seth R. Bowers
Williams & Connolly
Attorney Name: Xun Liu
Defendant Attorneys
2MSN Laboratories
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10723730 | Solid forms of a selective CDK4/6 inhibitor | Jul 28, 2020 |
